НовостиBenzingaMorgan Stanley Maintains Equal-Weight on Lakefront Biotherapeutics, Raises Price Target to $27 Morgan Stanley Maintains Equal-Weight on Lakefront Biotherapeutics, Raises Price Target to $27 Benzinga 2026.11.16 15:19 (GMT+0) Открыть на Benzinga Другие новости